betahistine sold brand name serc among others antivertigo medication commonly prescribed balance disorders alleviate vertigo symptoms first registered europe treatment ménières disease current evidence support efficacy treating betahistine believed positive effects treatment ménières disease recent evidence casts doubt studies use betahistine showed reduction symptoms vertigo lesser extent tinnitus subjects conclusive evidence lacking present oral betahistine approved treatment ménière disease vestibular vertigo countries worldwide reportedly prescribed million patients however betahistine approved marketing united states past decades disagreement efficacy cochrane library concluded trials suggested reduction vertigo betahistine suggested reduction tinnitus effects may caused bias methods one trial good methods showed effect betahistine tinnitus compared placebo patients none trials showed effect betahistine hearing loss serious adverse effects found betahistine betahistine also undergoing clinical trials treatment attention deficit hyperactivity disorder betahistine contraindicated patients pheochromocytoma patients bronchial asthma history peptic ulcer need closely monitoredcitation needed patients taking betahistine may experience following side betahistine may also cause several digestiverelated side effects package insert serc trade name betahistine states patients may experience several gastrointestinal side effects may include nausea upset stomach vomiting diarrhea dry mouth stomach cramping symptoms usually serious subside doses patients experiencing chronic digestive problems may lower dose minimum effective range taking betahistine meals additional digestive problems may require patients consult physician order find possible suitable alternative people taking betahistine may experience several side effects ranging mild serious package insert serc states patients may experience nervoussystem side effects including headache nervous system events may also partly attributable underlying condition rather medication used treat study jeckthole wagner also reports patients may experience headache liver problems including increased liver enzymes bileflow disturbances side effects persist outweigh relief symptoms original condition may warrant patient consult physician adjust change medication betahistine strong antagonist histamine receptor weak agonist histamine betahistine two mechanisms action primarily weak agonist receptors located blood vessels inner ear gives rise local vasodilation increased permeability helps reverse underlying problem endolymphatic hydrops importantly betahistine powerful antagonistic effects receptors thereby increasing levels neurotransmitters histamine acetylcholine norepinephrine serotonin gaba released nerve endings increased amounts histamine released histaminergic nerve endings stimulate receptors stimulation explains potent vasodilatory effects betahistine inner ear well documented betahistine seems dilate blood vessels within inner ear relieve pressure excess fluid act smooth muscle postulated betahistines increase level serotonin brainstem inhibits activity vestibular nuclei betahistine comes tablet form well oral solution taken orally rapidly completely absorbed mean plasma elimination halflife hours excretion virtually complete urine within hours plasma protein binding low betahistine transformed aminoethylpyridine hydroxyethylpyridine excreted urine pyridylacetic acid evidence one metabolites aminoethylpyridine may active exert effects similar betahistine ampullar betahistine chemically formulated dihydrochloride salt chemical structure closely resembles phenethylamine histaminecitation needed betahistine marketed number brand names including veserc serc hiserk betaserc vergocitation needed betahistine widely used available europe including united approved food drug administration early ménières disease approval later withdrawn lack evidence efficacy withdrawal upheld us court appeals needed httpsenwikipediaorgwikibetahistine